While the total number of gut bacteria doesn't differ between HIV-negative and HIV-positive people, the composition of the microorganisms changes with HIV infection, according to research presented at CROI 2016.
With buildings leveled by arson and systematic neglect, its population crammed into debilitated and overcrowded housing without access to basic public safety and public health services, the inescapable poverty of the Bronx provided fertile ground for...
Flu season can bring anxiety for people living with HIV and their health care providers. But do HIV-positive people have more severe symptoms of flu than people who are not living with HIV? In this interview, Christina Schofield, M.D., shares her stu...
HIV treatment as prevention has become a well-known and powerful tool in the global HIV response. In this interview, Mark Sulkowski, M.D., discusses whether a similar approach could be used in the prevention of hepatitis C.
No Difference in Neuropsychological Test Results Between Early and Delayed Treatment in START Substudy
Neuropsychological test results were similar for those who started antiretroviral therapy immediately and those who waited before starting, according to a substudy in the START study.
People randomized to begin antiretroviral therapy (ART) immediately in the international START trial had steeper declines in bone mineral density (BMD) than people randomised to delayed therapy.
In general, tenofovir alafenamide (TAF) is safe, with improvements in bone and kidney health over tenofovir disoproxil fumarate (TDF). However, those with severe kidney disease may not see improvements in kidney health, according to a recent study....
Hypogonadism, or low testosterone, affected more than one in 10 HIV-positive men in a preliminary single-center study in France. That rate is two times higher than in the general population of similarly aged men.
In rural areas, scarce clinical resources exist for many people living with chronic infectious diseases -- or for the clinicians who provide care for them. But a program called Project ECHO is trying to turn that tide.
What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.